Active Ingredient
(in each extended-release tablet)
Guaifenesin USP 1200 mg
The following Structured Product Label (SPL) was submitted to the FDA by Vespyr Brands Llc for the product Guaifenesin (NDC 71179-002). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.
This specific version of the label includes detailed information regarding active ingredient, purpose, uses, warnings, ask a doctor before use if you have, stop use and ask a doctor if, if pregnant or breast-feeding,, keep out of reach of children., and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.
(in each extended-release tablet)
Guaifenesin USP 1200 mg
Expectorant
Do not use
ask a health professional before use.
In case of overdose, get medical help or contact a Poison Control Center right away (1-800-222-1222).
colloidal silicon dioxide, hypromellose, magnesium stearate, microcrystalline cellulose, povidone, and pregelatinised starch (maize)
call toll-free 1-855-874-0970 (English/Spanish) weekdays. You may also report side effects to this phone number.
DISTRIBUTED BY:
Vespyr Brands®, Inc.
East Windsor, NJ 08520
Made in India
Code: AP/DRUGS/04/2016
* Please review the disclaimer below.